Under the terms of the deal, Lygos and Ginkgo plan to advance two research and development programs over approximately two years. Ginkgo will leverage its expertise in strain development and metabolic engineering to design and optimize microorganisms to efficiently produce Lygos’ organic acid targets. The acids are used to produce biodegradable formulations and polymer-based products used in consumer, agricultural, and industrial markets.
“Many specialty organic acids rely on environmentally damaging and costly production processes. We’re excited to be working with Lygos to replace some of those harmful production methods with sustainable, environmentally friendly biomanufacturing processes,” said Ena Cratsenburg, Chief Business Officer at Ginkgo Bioworks.
Lygos CEL Eric Steen, says the partnership will enable Lygos to augment its development timelines, allocate more research and development, and accelerate product commercialization programs.